Elevated interleukin-6 and adverse outcomes in COVID-19 patients: a meta-analysis based on adjusted effect estimates

This study aimed to evaluate the association of interleukin-6 (IL-6) level with the poor outcomes in coronavirus disease 2019 (COVID-19) patients by utilizing a meta-analysis based on adjusted effect estimates. We searched the keywords from PubMed, Web of Science, and EMBASE on August 14, 2020. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Peihua, Shi, Li, Xu, Jie, Wang, Yadong, Yang, Haiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567652/
https://www.ncbi.nlm.nih.gov/pubmed/33067641
http://dx.doi.org/10.1007/s00251-020-01179-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567652/
https://www.ncbi.nlm.nih.gov/pubmed/33067641
http://dx.doi.org/10.1007/s00251-020-01179-1

Ejemplares similares